REGAN MARTIN: Open Payments
NPI 1467833871 · JOPLIN, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$549 in 40 payments from 8 companies in 2025. Trend: 2023 $709 · 2024 $687 · 2025 $549
Food & beverage: $549
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 11 | $187 |
| Amgen Inc. | 17 | $144 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| ABBVIE INC. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Astellas Pharma US Inc | 1 | $25 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Lilly USA, LLC | 1 | $14 |
Products named: Ozempic, OTEZLA, VOQUEZNA, BREZTRI, UBRELVY, EVENITY, Veozah, CREXONT.
Industry payments across MO — which companies pay providers there.
